Werewolf Therapeutics HOWL Balance Sheet (2020-2026)

NASDAQ HOWL
$0.98 +0.02 (+2.06%)
As of: Sep 10, 2026 · 3:08 PM EDT
Reported Financials

Werewolf Therapeutics Quarterly Balance Sheet

Periods 26 quarters
Latest Jun 2026

Werewolf Therapeutics reported total assets of $24.16M and total liabilities of $7.86M for the quarter ended Jun 2026, down 73.9% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
170.44M157.53M143.71M145.71M140.45M129.31M147.87M137.45M130.06M134.34M139.19M135.30M122.83M111.00M92.04M77.60M65.71M57.05M46.50M22.00M
Receivables - NetNet Receivables
2.80M5.00M0.90M0.40M0.30M0.50M
Receivables - OtherOther Receivables
2.22M2.08M6.93M6.25M6.93M5.91M-4.56M0.78M0.55M0.46M-0.46M
Receivables
9.73M10.91M-3.66M1.18M0.84M0.96M-0.46M
Prepaid Assets
3.97M3.54M1.73M6.23M6.84M3.96M2.44M3.02M3.29M2.68M2.32M2.94M2.54M2.07M2.42M2.84M2.46M1.54M2.28M0.91M
Current Assets
174.40M161.07M145.44M154.16M151.59M140.20M156.56M147.40M139.26M138.37M142.28M138.79M125.83M113.07M94.46M80.44M68.17M58.59M48.73M22.89M
Non-Current Assets
Property, Plant & Equipment (Net)
0.79M2.91M6.14M9.03M9.17M8.99M8.70M8.38M8.34M7.96M7.53M7.09M6.76M6.32M5.90M5.49M5.09M4.69M4.29M1.26M
Other Non-Current Assets
1.30M1.21M1.21M1.21M1.21M1.38M21.20M21.20M21.02M21.02M21.03M1.21M1.22M1.22M0.89M0.90M0.90M0.90M
Non-Current Assets
3.97M18.18M19.20M21.16M20.84M20.05M38.51M37.84M37.13M36.46M35.32M14.91M14.20M13.86M12.78M12.13M11.45M10.81M9.29M1.26M
Assets
178.38M179.25M164.63M175.33M172.42M160.25M195.07M185.24M176.39M174.83M177.60M153.70M140.04M126.93M107.24M92.57M79.63M69.40M58.02M24.16M
Liabilities
Current Liabilities
Accounts Payables
1.46M2.04M1.38M2.59M1.39M1.22M2.11M1.49M1.39M1.34M1.59M1.47M1.24M3.04M0.99M2.77M1.08M0.75M3.57M1.94M
Notes Payables
1.67M6.67M11.67M2.40M6.00M28.24M28.83M
Payables
1.46M2.04M1.38M2.59M1.39M1.22M2.11M1.49M3.05M8.00M13.26M1.47M1.24M3.04M0.99M5.17M7.08M28.99M32.40M1.94M
Accumulated Expenses
5.57M8.77M8.19M14.09M13.93M14.15M13.32M9.94M7.97M8.86M6.21M8.70M9.90M10.59M9.27M8.54M9.02M5.41M4.51M5.92M
Other Accumulated Expenses
11.82M10.50M6.53M4.15M1.61M
Current Leases
0.74M1.07M1.46M1.87M2.02M2.08M2.15M1.97M1.60M1.61M1.24M1.27M1.32M1.56M1.41M1.45M1.50M1.75M1.60M
Current Deferred Revenue
7.66M2.39M2.40M1.34M0.93M
Total Current Liabilities
7.78M11.87M11.03M30.37M27.80M23.99M21.72M15.01M14.44M19.38M21.21M11.44M12.46M15.18M11.67M15.17M17.60M36.15M38.52M7.86M
Non-Current Liabilities
Non-Current Debt
39.06M39.14M37.56M32.66M27.75M25.16M25.62M26.09M26.59M24.70M21.66M
Non-Current Deffered Revenue
0.01M1.30M0.34M1.13M1.20M0.80M0.60M0.43M0.43M
Preferred Stock Liabilities
Operating Leases
1.30M14.59M14.29M15.55M15.16M12.60M12.04M11.71M11.35M10.99M10.62M10.24M9.84M9.44M9.02M8.59M8.14M7.68M7.22M
Other Non-Current Liabilities
0.19M0.19M0.19M2.84M2.73M2.83M2.66M2.64M2.61M0.76M0.09M
Total Non-Current Liabilities
9.07M26.46M45.30M41.29M37.72M74.00M66.64M63.94M63.46M46.84M47.92M50.71M47.27M48.46M47.40M43.83M45.73M7.86M
Total Liabilities
9.07M26.46M25.31M45.49M41.48M37.91M74.00M66.64M63.94M63.46M60.01M49.69M50.66M53.54M49.93M51.10M50.01M44.59M45.82M7.86M
Shareholder's Equity
Total Debt
39.06M39.14M39.23M39.32M39.41M25.16M25.62M26.09M26.59M27.11M27.66M28.24M28.83M
Common Equity
169.30M152.79M139.32M129.84M130.95M122.34M121.07M118.60M112.44M111.37M117.59M104.02M89.38M73.39M57.31M41.46M29.61M24.80M12.20M16.29M
Liabilities and Shareholders Equity
178.38M179.25M164.63M175.33M172.42M160.25M195.07M185.24M176.39M174.83M177.60M153.70M140.04M126.93M107.24M92.57M79.63M69.40M58.02M24.16M
Retained Earnings
404.33M405.68M407.55M412.67M425.72M429.04M439.76M442.38M444.51M455.44M477.85M481.53M483.56M487.97M489.98M492.12M496.64M500.21M501.14M501.56M
Treasury Shares